Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Ruth H. Morrison

Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26
Apr 1, 2026, 15:18 | Science
Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a…
Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm
Nov 26, 2025, 04:51 | Science
Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm
Emma P. with Clinical Research Professionals shared a post on LinkedIn: "Apixaban for Extended Treatment…
Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
Oct 12, 2025, 10:14 | Science
Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
Hatim Lokhandwala, Clinical Research Coordinator, Hope & Healing Cancer Services LLC, shared a post on LinkedIn:…
HI-PRO Trial: Apixaban for Long-Term Prevention of Recurrent VTE
Sep 30, 2025, 06:42 | Science
HI-PRO Trial: Apixaban for Long-Term Prevention of Recurrent VTE
The New England Journal of Medicine (NEJM) has shared a post on X: “In patients with…
Apixaban: Low-Dose Long-Term Use After Provoked VTE Shows Benefits
Sep 21, 2025, 16:25 | Science
Apixaban: Low-Dose Long-Term Use After Provoked VTE Shows Benefits
Christopher Cannon, Editor in Chief, Harvard Health Publishing, shared a post on LinkedIn: "Low-dose Apixaban…
Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results
Aug 31, 2025, 07:23 | Science
Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results
  Marc Carrier, Professor at Ottawa Hospital Research Institute, has posted on X: ''New in…
Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results
Aug 30, 2025, 14:43 | Science
Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results
Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, shared a…
All: 7 Posts: 1 - 100
NewsFeed